SIGY (Sigyn Therapeutics) Interest Expense: $-0.55 Mil (TTM As of Sep. 2025)


What is Sigyn Therapeutics Interest Expense?

Sigyn Therapeutics SIGY Interest Expense is $-0.55 Mil as of Sep. 2025. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sigyn Therapeutics's interest expense for the three months ended in Sep. 2025 was $ -0.19 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.55 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sigyn Therapeutics's Operating Income for the three months ended in Sep. 2025 was $ -0.39 Mil. Sigyn Therapeutics's Interest Expense for the three months ended in Sep. 2025 was $ -0.19 Mil. Sigyn Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sigyn Therapeutics  (OTCPK:SIGY) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sigyn Therapeutics's Interest Expense for the three months ended in Sep. 2025 was $-0.19 Mil. Its Operating Income for the three months ended in Sep. 2025 was $-0.39 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2025 was $2.06 Mil.

Sigyn Therapeutics's Interest Coverage for the quarter that ended in Sep. 2025 is calculated as

Sigyn Therapeutics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Sigyn Therapeutics Interest Expense Historical Data

* Premium members only.

The historical data trend for Sigyn Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigyn Therapeutics Interest Expense Chart

Sigyn Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.34 -0.46 -0.78 -2.04 -0.86

Sigyn Therapeutics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.36 -0.11 -0.12 -0.12 -0.19

Sigyn Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.55 Mil mean?
Sigyn Therapeutics (SIGY) has a Interest Expense of $-0.55 Mil as of Sep. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sigyn Therapeutics and its competitors.
Is Sigyn Therapeutics' Interest Expense too high?
Sigyn Therapeutics' current Interest Expense is $-0.55 Mil.
How does Sigyn Therapeutics' Interest Expense compare to RGBP and ENDV?
Sigyn Therapeutics' Interest Expense of $-0.55 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sigyn Therapeutics and its competitors. Sigyn Therapeutics's current Interest Expense is $-0.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigyn Therapeutics stock overvalued right now?
Sigyn Therapeutics (SIGY) has a current Interest Expense of $-0.55 Mil. The current Interest Expense is $-0.55 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Sigyn Therapeutics (SIGY), the current Interest Expense is $-0.55 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sigyn Therapeutics Business Description

Address 2468 Historic Decatur Road, Suite 140, San Diego, CA, USA, 92106
Sigyn Therapeutics Inc is a development-stage therapeutic technology company. Its business focus is the clinical advancement of Sigyn Therapy, a multi-function blood purification technology designed to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths world-wide. To support widespread implementation, the company designed Sigyn Therapy to be a single-use disposable device that is deployable on the world-wide infrastructure of hemodialysis and continuous renal replacement therapy machines already located in hospitals and clinics.